Predicting severe bacterial infections in well-appearing febrile neonates: Laboratory markers accuracy and duration of fever

Pediatric Infectious Disease Journal

Volumn 29, Issue 3, 2010, Pages 227-232

  Bressan, Silvia ^a   Andreola, Barbara ^a   Cattelan, Francesca ^a   Zangardi, Tiziana ^a   Perilongo, Giorgio ^a   Da Dalt, Liviana ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

C reactive protein; Fever; Leukocytes; Neonate; Severe bacterial infection

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; EMERGENCY WARD; FEMALE; FEVER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEUTROPHIL COUNT; NEWBORN; OSTEOMYELITIS; PNEUMONIA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TERTIARY HEALTH CARE; URINARY TRACT INFECTION;

EID: 77649215396     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181b9a086     Document Type: Article

References (42)

1. Dagan R, Sofer S, Philip M, et al. Ambulatory care of febrile infants younger than 2 months of age classified as being at low risk for having serious bacterial infection. J Pediatr. 1988;112:355-360.
2. Garra G, Cunningham SJ, Crain EF. Reappraisal of criteria used to predict serious bacterial illness in febrile infants less than 8 weeks of age. Acad Emerg Med. 2005;12:921-925.
3. Dagan R, Powell KR, Hall CB, et al. Identification of infants unlikely to have serious bacterial infection although hospitalised for suspected sepsis. J Pediatr. 1985;107:855-860.
4. Wasserman GM, White CB. Evaluation of the necessity for hospitalization of the febrile infant less than three months of age. Pediatr Infect Dis J. 1990;9:163-169.
5. Broner CW, Polk SA, Sherman JM. Febrile infants less than eight weeks old: predictors of infection. Clin Pediatr. 1990;29:438-443.
6. Baskin MN, O'Rourke RJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriax-one. J Pediatr. 1992;120:22-27.
7. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med. 1993;329:1437-1441.
8. Jaskiewicz JA, McCarthy CA, Richardson AC, et al. Febrile infants at low risk for serious bacterial infection-an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group. Pediatrics. 1994;94:390-396.
9. Baker MD, Bell LM, Avner JR. The efficacy of routine outpatient management without antibiotics of fever in selected infants. Pediatrics. 1999; 103:627-631.
10. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics. 2001;108:311-316.
11. Herr SM, Wald ER, Pitetti RD, et al. Enhanced urinalysis improves identification of febrile infants ages 60 days and younger at low risk for serious bacterial illness. Pediatrics. 2001;108:866-871.
12. Chiu CH, Lyn TY, Bullard MJ. Application of criteria identyfying febrile outpatient neonates at low risk for bacterial infections. Pediatr Infect Dis J. 1994;13:946-949.
13. Chiu CH, Lin TY, Bullard MJ. Identification of febrile neonates unlikely to have bacterial infections. Pediatr Infect Dis J. 1997;16:59-63.
14. Ferrera PC, Bartfield JM, Snyder HS. Neonatal fever: utility of the Rochester criteria in determining low risk for serious bacterial infections. Am J Emerg Med. 1997;15:299-302.
15. Baker MD, Bell LM. Unpredictability of serious bacterial illness in febrile infants from birth to 1 month of age. Arch Pediatr Adolesc Med. 1999;153: 508-511.
16. Kadish HA, Loveridge B, Tobey J, et al. Applying outpatient protocols in febrile infants 1-28 days of age: can the threshold be lowered? Clin Pediatr. 2000;39:81-88.
17. Marom R, Sakran W, Antonelli J, et al. Quick identification of febrile neonates with low risk for serious bacterial infection: an observational study. Arch Dis Child Fetal Neonatal Ed. 2007;92:F15-F18.
18. Schwartz S, Raveh D, Toker O, et al. A week by week analysis of the low risk criteria for serious bacterial infection in febrile neonates. Arch Dis Child. 2009;94:287-292.
19. Cincinnati Children's Hospital Medical Center. Evidence Based Clinical Practice Guideline for Fever of Uncertain Source in Infants 60 Days of Age or Less. Cincinnati, OH: Cincinnati Children's Hospital Medical Center; 2003: 12.
20. Ishimine P. The evolving approach to the young child who has fever and no obvious source. Emerg Med Clin North Am. 2007;25:1087-1115, vii.
21. NICE Fever Guidelines, Clinical Guideline. Feverish Illness in Children: Assessment and Initial Management in Children Younger Than 5 Years. London: RCOG Press; 2007:65.
22. Baraff LJ. Management of infants and young children with fever without source. Pediatr Ann. 2008;37:673-679.
23. McCarthy PL, Scarpe MR, Spiesel SZ, et al. Observation scale to identify serious illness in febrile children. Pediatrics. 1982;70:802-809.
24. Montini G, Toffolo A, Zucchetta P, et al. Antibiotic treatment for pyelonephritis in children: multicenter randomized controlled non-inferiority trial. BMJ. 2007;335:386-392.
25. Campbell G. Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Stat Med. 1994;13:499-508.
26. Baraff LJ. Management of febrile neonates: what to do with low risk infants. Pediatr Infect Dis J. 1994;13:943-945.
27. Chiu CH, Lin TY. Application of the Rochester criteria in febrile neonates. Pediatr Infect Dis J. 1998;17:267-269.
28. Andreola B, Bressan S, Callegaro S, et al. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J. 2007;26: 672-677.
29. Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics. 2001;108:1275-1279.
30. Galetto-Lacour A, Gervaix A, Zamora SA, et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr. 2001;160:95-100.
31. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-Reactive Protein Tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics. 2003;112:1054-1060.
32. Fernández Lopez A, Luaces Cubells C, García García JJ, et al; Spanish Society of Pediatric Emergencies. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J. 2003;22:895-903.
33. Hsiao AL, Chen L, Baker MD. Incidence and predictors of serious bacterial infections among 57-to 180-day-old infants. Pediatrics. 2006;117:1695-1701.
34. Olaciregui I, Hernández U, Muñoz JA, et al. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin. Arch Dis Child. 2009;94:501-505.
35. Pratt A, Attia MW. Duration of fever and markers of serious infection in young febrile child. Pediatr Int. 2007;49:31-35.
36. Gervaix A, Galetto-Lacour A, Gueron T, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J. 2001;20:507-511.
37. Bigot S, Leblond P, Foucher C, et al. Usefulness of procalcitonin for the diagnosis of acute pyelonephritis in Children. Arch Pediatr. 2005;12:1075-1080.
38. Leroy S, Adamsbaum C, Marc E, et al. Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection. Pediatrics. 2005;115:e706-e709.
39. Leroy S, Breart G, Chalumeau M. Procalcitonin and vescicoureteral reflux in children with urinary tract infection: in reply. Pediatrics. 2005;116:1262.
40. Leroy S, Marc E, Adamsbaum C, et al. Prediction of vesicoureteral reflux after a first febrile urinary tract infection in children: validation of a clinical decision rule. Arch Dis Child. 2006;91:241-244.
41. Leroy S, Romanello C, Galetto-Lacour A, et al. Procalcitonin to reduce the number of unnecessary cystographies in children with a urinary tract infection: a European validation study. J Pediatr. 2007;150:89-95.
42. Brik R, Hamissah R, Shehada N, et al. Evaluation of febrile infants under 3 months of age: is routine lumbar puncture warranted? Isr J Med Sci. 1997;33:93-97.